Zantac: Understanding the Link to Breast Cancer
Breast cancer is the most common cancer affecting American women; an estimated one in eight will develop breast cancer at some point in her lifetime. In 2020 alone, well over a quarter of a million American women are projected to receive a breast cancer diagnosis.
The breast cancer rate in the United States could be related to the widely-used antacid medication Zantac (ranitidine), which was once the highest-selling prescription drug. Recently, the U.S. Food and Drug Administration (FDA) ordered Zantac (including over the counter and generic ranitidine) to be removed from shelves due to the link between the popular antacid and cancer. Zantac contains a toxic substance known as NDMA, which the World Health Organization (WHO), the U.S. Environmental Protection Agency (EPA) and the FDA all classify as a cancer-causing substance.
The NDMA in Zantac is linked to several forms of cancer, including breast cancer. A major study found that Zantac more than doubles the risk of breast cancer (ductal carcinoma).
The national law firm of Baum Hedlund Aristei & Goldman, PC is one of the leading firms in the country representing thousands of people who developed cancer after taking Zantac (ranitidine). More than 1,500 women diagnosed with breast cancer after Zantac (ranitidine exposure) have retained our firm to represent their interests in the Zantac litigation, which involves multiple defendants.
If you or a family member took Zantac and later developed breast cancer, you need a legal team that knows what it takes to win big cases against big companies. In 2018 and again in 2019, our firm’s attorneys prevailed in cancer court cases that culminated in $289 million and $2.055 billion jury verdicts against Bayer AG, one of the largest pharmaceutical and life sciences corporations in the world. Put your trust in a law firm with proven results.
Call Baum Hedlund at (855) 948-5098 or contact us online to see if you are eligible to seek compensation in a Zantac breast cancer lawsuit.
Does Zantac Cause Breast Cancer?
In 2008, researchers conducted a large study designed to answer this very question. The study found that ranitidine more than doubled the risk of breast cancer (ductal carcinoma), an effect that was even more pronounced in subjects with specific gene mutations.
The study was one of the largest to examine the link between certain histamine2-receptor (H2-receptor) blockers—the class of drugs to which ranitidine belongs—and breast cancer. Researchers evaluated the risk of breast cancer among 1,941 cases and 1,476 controls between the ages of 55 and 79.
The study found a 2.2-fold increased risk of ductal carcinoma among those currently using ranitidine. In light of this discovery, the authors called for further study on the link between ranitidine and breast cancer.
Should I File a Zantac Breast Cancer Lawsuit?
Individuals diagnosed with breast cancer after taking Zantac, Zantac OTC, or generic ranitidine may be eligible to file a lawsuit and recover damages for:
- Lost wages or income
- Medical bills
- Physical pain and suffering
- Emotional pain and suffering
- Disability or permanent injury
- Loss of consortium (wrongful death)
- Punitive damages
Rather than warning the public of this severe health hazard, our lawsuits accuse the defendants of concealing the cancer link from the medical community and consumers while collecting billions in profits from drug sales.
Contact us today or call (855) 948-5098 for more information on how we can assist you with filing a Zantac lawsuit.
Top Legal Minds in the Country- From Best Lawyers® Best Law Firms
I Can’t Imagine a Better Law Firm- Best Law Firms Survey
Diligent & Professional Representation- W.T.
Our Best Interest Was Always Number One on Your List- G.C. & C.C
We Have Never Met a More Wonderful Group of People- The B. Family